✦ LIBER ✦

Adjuvant Subcutaneous Interleukin-2 in Patients with Resected Renal Cell Carcinoma: A Pilot Study

✍ Scribed by Navneet S. Majhail; Laura Wood; Paul Elson; James Finke; Thomas Olencki; Ronald M. Bukowski

Book ID: 115075919
Publisher: CIG Media Group, LP.
Year: 2006
Tongue: English
Weight: 145 KB
Volume: 5
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2006.n.017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Subcutaneous low-dose recombinant interl

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma

✍ Gaston, R; Oskam, R; Philip, T; Ravaud, A; Négrier, S; Cany, L; Merrouche, Y; Le 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 876 KB

A pilot study of thalidomide in patients

A pilot study of thalidomide in patients with progressive metastatic renal cell carcinoma

✍ Danai D. Daliani; Christos N. Papandreou; Peter F. Thall; Xuemei Wang; Cherie Pe 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

## Background: The highly vascular nature of renal cell carcinoma (rcc) suggests that angiogenesis inhibition may be therapeutic for patients with this disease. thalidomide inhibits basic fibroblast growth factor and vascular endothelial growth factor (vegf)-induced angiogenesis. ## Methods: In a

Randomized Trial of Adjuvant Thalidomide

Randomized Trial of Adjuvant Thalidomide Versus Observation in Patients With Completely Resected High-Risk Renal Cell Carcinoma

✍ Vitaly Margulis; Surena F. Matin; Nizar Tannir; Pheroze Tamboli; Yu Shen; Marisa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Subcutaneous administration of interleuk

Subcutaneous administration of interleukin 2 and interferon-alpha-2b in advanced renal cell carcinoma: a confirmatory study

✍ Facendola, G; Locatelli, MC; Pizzocaro, G; Piva, L; Pegoraro, C; Pallavicini, EB 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 891 KB

Pharmacokinetic Study of Interleukin-2 F

Pharmacokinetic Study of Interleukin-2 Following Intravenous Injection in Hemodialysis Patients With Renal Cell Carcinoma

✍ Sadanori Kamikawa; Toshikado Sugimoto; Toshihiro Asai; Keiichi Ishii; Taku Kim 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB

A phase II study of interferon α and low

A phase II study of interferon α and low-dose subcutaneous interleukin-2 in advanced renal cell carcinoma

✍ A. Piga; Paolo Giordani; Agata Quattrone; Marco Giulioni; Giorgio De Signoribus; 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 72 KB